Legal
Pharming categorically denies having had any involvement in the alleged abstraction of proprietary information by Dr Joseph Chiao from his former employer CSL
Frank Reynolds, chief executive officer of PixarBio, made outlandish claims to investors and even compared himself to Apple’s Steve Jobs and Jesus Christ. Those were the claims of a witness made on the witness stand in an ongoing securities fraud trial.
AmerisourceBergen, McKesson and Cardinal Health are in the midst of negotiations for a multi-billion settlement over litigation filed against each of the companies for their role in distributing opioid drugs across the country.
The jury found the company failed to warn patients of a side effect causing young men who used the drug to grow breasts (gynecomastia).
Acorda Therapeutics’ attempt to preserve its patent protection for multiple sclerosis drug Ampyra hit the proverbial wall Monday when the U.S. Supreme Court refused to hear the company’s appeal of a lower court ruling.
On Friday, Holmes’ attorneys from the firm Cooley LLP, who are representing her in a civil lawsuit brought against Theranos and Walgreens, filed a motion with the courts to withdraw from the case over Holmes’ failure to pay them for their work.
In 2017, a lawsuit was filed alleging that Eli Lilly and Bayer, as well as other companies, attempted to use the free nursing services as a way to boost sales of diabetes drugs, such as Humalog and Humulin, as well as other drugs.
Johnson & Johnson reached a $20 million settlement agreement with two Ohio counties for its role in the opioid crisis ahead of a watershed trial set to take place later this month involving multiple companies and lawsuits.
Following Purdue Pharma’s Chapter 11 filing last month, other opioid makers are exploring ways to settle their own litigation problems by participating in the OxyContin drugmaker’s bankruptcy proceedings.
On Monday, the House Republican resigned his congressional seat ahead of the expected plea.
PRESS RELEASES